Epilepsy Therapy Project Appoints Joyce Cramer President and Names Three VPs Recognized for Leadership in the Field of Epilepsy

Reston, VA, December 4, 2007 — The Epilepsy Therapy Project (ETP), a non-profit organization dedicated to advancing new therapies for people living with epilepsy, today announced that it has appointed Joyce A. Cramer as President. Ms. Cramer, a research scientist at Yale University School of Medicine, has been a member of ETP’s Board of Directors since its inception in 2001, and has been instrumental to the organization in its mission of advancing translational medicine in epilepsy. She succeeds William Braunlich, who will continue to serve on the Board of Directors.

“We are delighted Joyce Cramer has accepted the role of President,” said Warren Lammert, Chairman and Co-founder. “As the Epilepsy Therapy Project progresses in its goals of actively funding and advancing new epilepsy therapies into clinical development, and providing valuable information to patients, families and medical professionals through its award-winning website, www.epilepsy.com, Joyce’s knowledge and expertise will help carry the organization to a new level. Joyce is a dynamic leader in the field who embodies the mission of our organization and provides a unique brand of leadership to the cause. Under her direction, ETP will continue to bring together financial, scientific and business resources to encourage the commercialization of new epilepsy therapies.”

Ms. Cramer’s career includes several decades of work in epilepsy and clinical trials to evaluate treatment outcomes in the fields of neurology and pharmacology. She developed methods for the evaluation of antiepileptic drug efficacy and adverse effects, study design and management, and enhancement of medication compliance, as well as instruments to assess quality of life, treatment satisfaction, and other patient-reported outcomes. She is well-published in medicine, neurology, psychiatry, research design, medication compliance, quality of life, and other patient-reported outcomes. Ms. Cramer’s professional activities have included positions as Treasurer of the American Epilepsy Society (AES) and AES Board of Directors, among others, and she serves on several editorial boards.

“I have watched the phenomenal growth of ETP from my perspective as an advisor since 2001,” said Ms. Cramer. Warren Lammert founded and invested in his vision of creating an organization that helps to overcome the hurdles to the successful commercialization of innovative epilepsy therapies. He has assembled a stellar team of scientific advisors and personnel, of which I am delighted to be a part. I hope to follow ETP’s mission by using my resources to move progress in epilepsy forward. I want to bring my contacts in the academic field out of their laboratories with fresh ideas, help them refine their projects with grants, and introduce them to investors who can support development of new drugs and devices to stop or prevent seizures.”

The Epilepsy Therapy Project also announced the appointment of three new Vice Presidents: Orrin Devinsky, M.D., Professor of Neurology, Neurosurgery, and Psychiatry at NYU School of Medicine, has been named Vice President for Development; Jacqueline French, M.D., Professor of Neurology and Co-Director, Pennsylvania Epilepsy Center, University of Pennsylvania, has been named Vice President for Research; and Steven Schachter, M.D., Editor-in-Chief, epilepsy.com, Professor of Neurology, Harvard Medical School, Director of Research Beth Israel Deaconess Medical Center Department of Neurology, has been named Vice President for Medical Information.

“Orrin, Jackie and Steve are pre-eminent researchers in the field of epilepsy,” said Lammert, “and they have been invaluable advisors to ETP since its inception. We honor them for their unswerving commitment to our cause and are pleased to formalize our relationship with them with their appointments as Vice President.”

About the Epilepsy Therapy Project

The Epilepsy Therapy Project is a non-profit organization whose mission is to advance new therapies for people living with epilepsy. Founded in 2002 by a group of parents, distinguished physicians and researchers, the Epilepsy Therapy Project supports the commercialization of new therapies through direct grants and investments in promising academic and commercial projects. The organization has raised over six million dollars towards its mission. Learn more at www.epilepsy.com.

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline
P